Efficacy of rifaximin, a poorly absorbed rifamycin antimicrobial agent, for hepatic encephalopathy in Japanese patients.

Yasunari HiramineHirofumi UtoSeiichi MawatariShuji KanmuraYasushi ImamuraTakuya HiwakiAkiko SaishojiAtsuko KakiharaShigeho MaenoharaKoichi TokushigeAkio Ido

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2021)

Rifaximin was associated with decreased blood ammonia levels, lower incidence of OHE, and fewer hospitalizations in Japanese patients with HE. In addition, serum albumin level was an important predictor on efficacy of rifaximin.

Keyphrases

irritable bowel syndrome
staphylococcus aureus
early onset